Diagnostic Performance of [<sup>18</sup>F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer

Diagnostic Performance of [<sup>18</sup>F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer

Positron emission tomography using [<sup>18</sup>F]fluorodeoxyglucose (FDG PET) potentially underperforms for staging of patients with grade 1–2 estrogen receptor positive (ER+) breast cancer. The aim of this study was to retrospectively investigate the diagnostic accuracy of FDG PET in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ramsha Iqbal, Lemonitsa H. Mammatas, Tuba Aras, Wouter V. Vogel, Tim van de Brug, Daniela E. Oprea-Lager, Henk M. W. Verheul, Otto S. Hoekstra, Ronald Boellaard, Catharina W. Menke-van der Houven van Oordt
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
positron emission tomography (PET)
[<sup>18</sup>F]FDG
breast cancer
estrogen receptor
staging
Medicine (General)
R5-920
Accès en ligne:https://doaj.org/article/d8c988063f0c45489f71114b436b3760
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/d8c988063f0c45489f71114b436b3760

Documents similaires